source
- Former Genentech researcher Lélia Delamarre appointed head of R&D at Medici Therapeutics; Intellia hires Scholar Rock CMOLélia Delamarre, a former senior scientist at Genentech, announced on LinkedIn that she will lead research and development at Medici Therapeutics, a cancer‑focused biotech backed by ARCH venture pa…
- Estuary sails into kidney disease space with $103M for gene therapiesEstuary Biotherapeutics is seeking to address the root cause of autosomal dominant polycystic kidney disease with two gene therapy programs based on science from Yale.BioSpace · 5d ago↗ source
- OrbiMed raises two new life sciences funds worth $3B with one aiming for Asia